Korean J Med > Volume 77(2); 2009 > Article
The Korean Journal of Medicine 2009;77(2):143-151.
Current status and future strategies of antimicrobial resistance in Korea
Jae-Hoon Song
항생제 내성의 국내 현황 및 대책
송 재 훈
Abstract
Antimicrobial resistance in major bacterial pathogens became a serious problem in the clinical practice. In Korean hospitals, prevalence rates of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and multidrug- resistant gram-negative bacilli are very high. In the community, macrolide-resistant Streptococcus pneumoniae and community- associated MRSA are major resistant pathogens. Infections caused by antimicrobial-resistant bacteria are associated with a greater likelihood of inappropriate antimicrobial therapy and poor clinical outcome. Physicians should have updated information and knowledge about current epidemiological status of resistance and appropriate use of antimicrobial agents. Appropriate use of antimicrobial agents, strict infection control, and development of new antibiotics and vaccines are important future strategies for the control of antimicrobial resistance. This review focuses on the current epidemiology and clinical implications of antimicrobial- resistant bacterial infections in Korea based on the published data for the past 10 years. (Korean J Med 77:143-151, 2009)
Key Words: Antimicrobial Resistance; Bacterial infections; Epidemiology; Korea


TOOLS
METRICS Graph View
  • 1,759 View
  • 93 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next